文献速递关节外科创伤骨科

庆大霉素缓释单层溶胶-凝胶涂层修饰羟基磷灰石钛的抗菌活性与生物相容性

The antimicrobial activity and biocompatibility of a controlled gentamicin-releasing single-layer sol-gel coating on hydroxyapatite-coated titanium.
PubMed 文献 · Bone Joint J · 2021-01-01

本研究开发了一种含1.25% w/v庆大霉素的单层杂化有机-无机溶胶-凝胶涂层,用于无骨水泥羟基磷灰石涂层钛骨科假体。体外实验显示涂层在1小时内释放庆大霉素超过敏感葡萄球菌最低抑菌浓度的10倍,48小时内洗脱超过99%,可完全根除浮游菌和已形成的生物膜,且间充质干细胞可黏附并分化为成骨细胞。小动物体内模型表明涂层钛/HA棒的骨整合与传统HA涂层相当。

要点

  • 涂层含1.25% w/v庆大霉素,1小时内释放量超过敏感葡萄球菌MIC的10倍。
  • 48小时内庆大霉素洗脱超过99%,可完全根除浮游菌和已形成的葡萄球菌生物膜。
  • 体内小动物模型中涂层钛/HA棒的骨整合与传统HA涂层相当。

核心结论

  • 该溶胶-凝胶技术可从生物陶瓷涂层的无骨水泥关节假体材料中释放庆大霉素,体外局部浓度超过抗生素骨水泥可达到的水平,体内动物模型骨愈合未受损。

研究设计与样本

  • 实验室研究:制备含1.25% w/v庆大霉素的溶胶-凝胶涂层,检测释放动力学、抗菌活性、生物相容性和物理结合力,所有测试n=3。
  • 体内小动物愈合模型:测试四种材料,每种材料n=6,将涂层应用于商用纯HA涂层钛棒表面。

主要发现

  • 涂层在1小时内释放庆大霉素超过敏感葡萄球菌菌株MIC的10倍。
  • 48小时内涂层中抗生素洗脱超过99%。
  • 对一组临床相关葡萄球菌的浮游菌和已形成生物膜均完全根除。
  • 间充质干细胞黏附于涂层表面并向成骨细胞分化,沉积钙并表达骨标志蛋白骨桥蛋白。
  • 体内小动物骨愈合模型中,抗生素溶胶-凝胶涂层钛/HA棒的骨整合与传统HA涂层表面相当。

关键数值与推荐

  • 庆大霉素浓度为1.25% w/v,类似于市售抗生素骨水泥中的浓度。
  • 1小时内释放量>10×MIC(针对敏感葡萄球菌菌株)。
  • 48小时内抗生素洗脱>99%。

临床怎么用

  • 该涂层技术可能通过局部释放庆大霉素为无骨水泥关节假体提供抗感染保护,且不影响骨整合。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study was to develop a single-layer hybrid organic-inorganic sol-gel coating that is capable of a controlled antibiotic release for cementless hydroxyapatite (HA)-coated titanium orthopaedic prostheses. METHODS: Coatings containing gentamicin at a concentration of 1.25% weight/volume (wt/vol), similar to that found in commercially available antibiotic-loaded bone cement, were prepared and tested in the laboratory for: kinetics of antibiotic release; activity against planktonic and biofilm bacterial cultures; biocompatibility with cultured mammalian cells; and physical bonding to the material (n = 3 in all tests). The sol-gel coatings and controls were then tested in vivo in a small animal healing model (four materials tested; n = 6 per material), and applied to the surface of commercially pure HA-coated titanium rods. RESULTS: The coating released gentamicin at > 10 × minimum inhibitory concentration (MIC) for sensitive staphylococcal strains within one hour thereby potentially giving effective prophylaxis for arthroplasty surgery, and showed > 99% elution of the antibiotic within the coating after 48 hours. There was total eradication of both planktonic bacteria and established bacterial biofilms of a panel of clinically relevant staphylococci. Mesenchymal stem cells adhered to the coated surfaces and differentiated towards osteoblasts, depositing calcium and expressing the bone marker protein, osteopontin. In the in vivo small animal bone healing model, the antibiotic sol-gel coated titanium (Ti)/HA rod led to osseointegration equivalent to that of the conventional HA-coated surface. CONCLUSION: In this study we report a new sol-gel technology that can release gentamicin from a bioceramic-coated cementless arthroplasty material. In vitro, local gentamicin levels are in excess of what can be achieved by antibiotic-loaded bone cement. In vivo, bone healing in an animal model is not impaired. This, thus, represents a biomaterial modification that may have the potential to protect at-risk patients from implant-related deep infection. Cite this article: Bone Joint J 2021;103-B(3):522-529.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Nichol T, Callaghan J, Townsend R, et al. The antimicrobial activity and biocompatibility of a controlled gentamicin-releasing single-layer sol-gel coating on hydroxyapatite-coated titanium. Bone Joint J. 2021. PMID: 33641411. doi:10.1302/0301-620X.103B3.BJJ-2020-0347.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。